Director, Discovery Sciences & Technologies

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Requirements

• PhD in pharmacology, cell-biology, biochemistry, or a related scientific discipline.
• Minimum of 8 years of industry experience in early-stage drug discovery.
• Experience integrating in vitro biochemical, biophysical, and cellular data to develop mechanistic understanding and inform project decisions.
• Track record of participating on cross-functional project teams in a matrixed discovery environment as a leader and as a contributor.
• Experience managing scientific teams and demonstrated ability to mentor and develop scientists through technical leadership and scientific coaching.
• Excellent communication skills and ability to influence across disciplines.

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits